Short answer · Medically reviewed summary · Last updated: 2026-04-07
The ICD-10 code for nephrogenic diabetes insipidus is N25.1, while the corresponding ICD-9 code is 588.1. These medical billing codes are used by healthcare providers and insurance companies to classify this specific condition, which is characterized by the kidneys' inability to respond to antidiuretic hormone. What is the clinical nature of nephrogenic diabetes insipidus? Nephrogenic diabetes insipidus is a rare disorder where the kidneys fail to concentrate urine despite adequate levels of vasopressin (antidiuretic hormone).
The ICD-10 code for nephrogenic diabetes insipidus is N25.1, while the corresponding ICD-9 code is 588.1. These medical billing codes are used by healthcare providers and insurance companies to classify this specific condition, which is characterized by the kidneys' inability to respond to antidiuretic hormone.
Nephrogenic diabetes insipidus is a rare disorder where the kidneys fail to concentrate urine despite adequate levels of vasopressin (antidiuretic hormone). Unlike central diabetes insipidus, which stems from a lack of hormone production in the brain, nephrogenic diabetes insipidus results from a defect in the kidney's ability to respond to that hormone. This leads to the hallmark symptoms of polyuria (excessive urination) and polydipsia (extreme thirst). At DiseaseMaps.org, we currently support a community of 66 people with nephrogenic diabetes insipidus, who share insights on managing the daily challenges of fluid balance and electrolyte regulation.
Diagnosis typically involves a water deprivation test followed by the administration of synthetic vasopressin (desmopressin). If the urine fails to concentrate after desmopressin is administered, it confirms a diagnosis of nephrogenic diabetes insipidus. When documenting this in electronic health records, clinicians use the ICD-10 code N25.1 (Nephrogenic diabetes insipidus) to ensure accurate billing and clinical tracking. Historically, the ICD-9 code 588.1 was utilized for this purpose before the transition to the updated classification system.
The condition can be either congenital or acquired. Congenital nephrogenic diabetes insipidus is most commonly caused by an X-linked recessive mutation in the AVPR2 gene, which encodes the vasopressin V2 receptor. Less frequently, it is caused by autosomal recessive or dominant mutations in the AQP2 gene. Because the X-linked form is the most prevalent, the disease predominantly affects males, though female carriers may sometimes show mild symptoms. Understanding the specific genetic cause is a vital step for families seeking genetic counseling.
Management of nephrogenic diabetes insipidus focuses on maintaining hydration and reducing urine volume. Clinical experts recommend the following approaches:
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.